Cargando…
Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
The acute treatment duration for major depressive disorder (MDD) is 8 weeks or more. Treatment of patients with MDD without predictors of treatment response and future recurrence presents challenges and clinical problems to patients and physicians. Recently, many neuroimaging studies have been publi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139562/ https://www.ncbi.nlm.nih.gov/pubmed/32245086 http://dx.doi.org/10.3390/ijms21062148 |